Novo Holdings A/S 13D and 13G filings for CYTEIR THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-03 5:02 pm Sale |
2023-07-28 | 13D | CYTEIR THERAPEUTICS INC CYTT |
Novo Holdings A/S | 1,547,136 4.400% |
-1,525,000 (-49.64%) |
Filing |
| 2023-07-26 4:58 pm Sale |
2023-07-20 | 13D | CYTEIR THERAPEUTICS INC CYTT |
Novo Holdings A/S | 3,072,136 8.700% |
-868,277 (-22.04%) |
Filing |
| 2022-09-30 4:42 pm Unchanged |
2022-09-27 | 13D | CYTEIR THERAPEUTICS INC CYTT |
Novo Holdings A/S | 3,940,413 11.100% |
0 (Unchanged) |
Filing |
| 2022-07-22 6:37 pm Sale |
2022-07-20 | 13D | CYTEIR THERAPEUTICS INC CYTT |
Novo Holdings A/S | 3,940,413 11.100% |
-900,000 (-18.59%) |
Filing |
| 2021-12-20 1:00 pm Unchanged |
2021-12-15 | 13D | CYTEIR THERAPEUTICS INC CYTT |
Novo Holdings A/S | 4,840,413 13.600% |
0 (Unchanged) |
Filing |
| 2021-06-25 4:33 pm Purchase |
2021-06-17 | 13D | CYTEIR THERAPEUTICS INC CYTT |
Novo Holdings A/S | 4,840,413 14.000% |
4,840,413 (New Position) |
Filing |